nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma
|
Badjatia, Nitika |
|
2010 |
28 |
4 |
p. 360-367 8 p. |
artikel |
2 |
Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium
|
Goebell, Peter J. |
|
2010 |
28 |
4 |
p. 409-428 20 p. |
artikel |
3 |
Commentary on Androgen receptor survival signaling is blocked by anti-{β}2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells
|
Koeneman, Kenneth S. |
|
2010 |
28 |
4 |
p. 459- 1 p. |
artikel |
4 |
Commentary on Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
|
Koeneman, Kenneth S. |
|
2010 |
28 |
4 |
p. 460- 1 p. |
artikel |
5 |
Commentary on Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
|
Koeneman, Kenneth S. |
|
2010 |
28 |
4 |
p. 462-463 2 p. |
artikel |
6 |
Commentary on Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis
|
Koeneman, Kenneth S. |
|
2010 |
28 |
4 |
p. 459-460 2 p. |
artikel |
7 |
Commentary on Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer
|
Koeneman, Kenneth S. |
|
2010 |
28 |
4 |
p. 461-462 2 p. |
artikel |
8 |
Commentary on The effects of telomerase inhibition on prostate tumor-initiating cells
|
Koeneman, Kenneth S. |
|
2010 |
28 |
4 |
p. 462- 1 p. |
artikel |
9 |
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
|
Lotan, Yair |
|
2010 |
28 |
4 |
p. 441-448 8 p. |
artikel |
10 |
Contents
|
|
|
2010 |
28 |
4 |
p. ii-iii nvt p. |
artikel |
11 |
Editorial Board
|
|
|
2010 |
28 |
4 |
p. i- 1 p. |
artikel |
12 |
Improving urologic cancer care
|
Skolarus, Ted A. |
|
2010 |
28 |
4 |
p. 347-349 3 p. |
artikel |
13 |
Information for Authors
|
|
|
2010 |
28 |
4 |
p. IBC- 1 p. |
artikel |
14 |
Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP
|
Hara, Noboru |
|
2010 |
28 |
4 |
p. 355-359 5 p. |
artikel |
15 |
Masthead
|
|
|
2010 |
28 |
4 |
p. iv- 1 p. |
artikel |
16 |
Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression
|
McConkey, David J. |
|
2010 |
28 |
4 |
p. 429-440 12 p. |
artikel |
17 |
Molecular pathways of urothelial development and bladder tumorigenesis
|
Castillo-Martin, Mireia |
|
2010 |
28 |
4 |
p. 401-408 8 p. |
artikel |
18 |
New concepts of biobanks—strategic chance for uro-oncology
|
Goebell, Peter J. |
|
2010 |
28 |
4 |
p. 449-457 9 p. |
artikel |
19 |
p53 immunohistochemistry in bladder cancer—a new approach to an old question
|
Goebell, Peter J. |
|
2010 |
28 |
4 |
p. 377-388 12 p. |
artikel |
20 |
Sarcoidosis and testicular cancer: A case series and literature review
|
Dick, Jonathan |
|
2010 |
28 |
4 |
p. 350-354 5 p. |
artikel |
21 |
Statistical consideration for clinical biomarker research in bladder cancer
|
Shariat, Shahrokh F. |
|
2010 |
28 |
4 |
p. 389-400 12 p. |
artikel |
22 |
Survey Section Editorial Board
|
|
|
2010 |
28 |
4 |
p. 458- 1 p. |
artikel |
23 |
The International Bladder Cancer Network
|
Grossman, H. Barton |
|
2010 |
28 |
4 |
p. 375-376 2 p. |
artikel |
24 |
Updated results of bladder-sparing trimodality approach for invasive bladder cancer
|
Zapatero, Almudena |
|
2010 |
28 |
4 |
p. 368-374 7 p. |
artikel |